Coronavirus: On Request For Sputnik 5 Vaccine Approval, Subject Expert Committee Seeks More Data From Dr Reddy's Laboratories: Sources
The Sputnik vaccine has an efficacy of 91.6 per cent. New Delhi: The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddys Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said. Dr Reddys Laboratories had approached the Drug Controller General of India (DGCI) on February 19 to get approval for the emergency use of Sputni...
Oxford Astrazeneca Covishield Panel Seeks More Data Expert Committee Serum Institute Of India Russian Direct Investment Fund Request For Sputnik
Source: ndtv.com